Article
KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren…
Journal of Inflammation Research · 2022 · Chiu YH, Chu CC, Lu CC, Liu FC, Tang SE, Chu SJ, Kuo SY, Chen HC
Key facts
| Title | KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case–Control Study |
|---|---|
| First author | Chiu YH, Chu CC, Lu CC, Liu FC, Tang SE, Chu SJ, Kuo SY, Chen HC |
| Journal | Journal of Inflammation Research |
| Published | Apr 8, 2022 |
| DOI | 10.2147/JIR.S352085 |
| Devices mentioned | K945163 |
| Product codes mentioned | LGX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1